Suchergebnisse - "Buti, Maria"

PubPharm (6)

1

COVID-19 and hepatitis B infection

enthalten in: Antiviral therapy | 2020

von Alqahtani, S. | Buti, M.

2

Ribavirin concentration determines treatment success of first-generation DAA-based chronic HCV therapy

enthalten in: Antiviral therapy | 2016

von de Kanter, C. | Buti, M. | DeMasi, R. | +6

3

Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4)

enthalten in: Antiviral therapy | 2015

von Hézode, C. | Alric, L. | Brown, A. | +14

4

Randomized controlled trial of the NS5A inhibitor daclatasvir plus peginterferon and ribavirin for HCV genotype-4 (COMMAND-4)

enthalten in: Antiviral therapy | 2015

von Hézode, C. | Alric, L. | Brown, A. | +13

5

HBV core region variability : effect of antiviral treatments on main epitopic regions

enthalten in: Antiviral therapy | 2011

von Homs, M. | Jardi, R. | Buti, M. | +6

6

Adefovir for chronic hepatitis B treatment : identification of virological markers linked to therapy response

enthalten in: Antiviral therapy | 2008

von Rodriguez-Frias, F. | Jardi, R. | Schaper, M. | +5

1
[1]